Literature DB >> 31479313

Cardiac Troponin Increase After Endurance Exercise.

Torbjørn Omland1,2, Kristin Moberg Aakre3,4.   

Abstract

Keywords:  Editorials; biomarkers; cardiovascular risk; exercise; myocardial injury; troponins

Mesh：

Substances：

Year:  2019        PMID： 31479313     DOI： 10.1161/CIRCULATIONAHA.119.042131

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  4 in total

Review 1.  Implications of the complex biology and micro-environment of cardiac sarcomeres in the use of high affinity troponin antibodies as serum biomarkers for cardiac disorders.

Authors:  Christopher R Solaro; R John Solaro
Journal:  J Mol Cell Cardiol       Date:  2020-05-19       Impact factor: 5.000

2.  Kinetics, Moderators and Reference Limits of Exercise-Induced Elevation of Cardiac Troponin T in Athletes: A Systematic Review and Meta-Analysis.

Authors:  Feifei Li; Will G Hopkins; Xuejing Wang; Julien S Baker; Jinlei Nie; Junqiang Qiu; Binh Quach; Kun Wang; Longyan Yi
Journal:  Front Physiol       Date:  2021-03-26       Impact factor: 4.566

3.  Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction.

Authors:  Elias Koppen; Torbjørn Omland; Alf Inge Larsen; Trine Karlsen; Axel Linke; Eva Prescott; Martin Halle; Håvard Dalen; Charles Delagardelle; Torstein Hole; Emeline M van Craenenbroeck; Paul Beckers; Øyvind Ellingsen; Patrick Feiereisen; Torstein Valborgland; Vibeke Videm
Journal:  ESC Heart Fail       Date:  2021-03-23

4.  The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients.

Authors:  Ola Hammarsten; Pontus Ljungqvist; Björn Redfors; Mathias Wernbom; Hannes Widing; Bertil Lindahl; Sabin Salahuddin; Ruwayda Sammantar; Sandeep Jha; Annica Ravn-Fischer; Magnus Brink; Magnus Gisslen
Journal:  Clin Chim Acta       Date:  2022-01-05       Impact factor: 3.786
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.